This is a service of EIN News a digital news provider
Thursday November 26, 2009
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Anthrax Drugs News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Anthrax Drugs News

Sort by: relevance (24 hours) relevance date
  • Human Genome sees FDA delay with anthrax treatment 17 Nov 2009 05:11 GMT
    ... Human Genome sees FDA delay with anthrax treatment ROCKVILLE, Md. -- Human Genome Sciences Inc. ... Sciences Inc. said Monday the Food and Drug Administration will not approve the company's anthrax ...

  • BioWatch: HGS seeks OK for hepatitis C treatment 26 Nov 2009 10:12 GMT
    ... federal regulatory approval to market its new treatment for hepatitis C. The Rockville biotech is ... could total $507.5 million, HGS said. The drug is made by genetically fusing human albumin, ... the FDA for more information about its anthrax treatment, for which the company seeks marketing ...

  • FDA: more info needed on anthrax drug 17 Nov 2009 01:32 GMT
    ... FDA: more info needed on anthrax drug Updated: Monday, 16 Nov 2009, 11:53 AM ... Administration will not approve the company's anthrax treatment until it receives additional information on the ...

  • FDA Requests More Info On HGS Anthrax Drug 20 Nov 2009 04:34 GMT
    ... FDA Requests More Info On HGS Anthrax Drug Drug Discovery & Development - November 18, ... Administration will not approve the company's anthrax treatment until it receives additional information on the ...

  • Human Genome Sciences submitted application for new drug Zalbin 25 Nov 2009 16:13 GMT
    ... year to federal regulators to sell a drug on the market, this most recent being for its hepatitis C treatment called Zalbin. With these applications, including a ... to the for approval to sell its anthrax treatment, though that submission hit a stumbling ...

  • UPDATE 2-FDA denies approval for Human Genome's anthrax drug 17 Nov 2009 02:55 GMT
    ... Sciences Inc ( ) said the U.S. health regulators declined to approve its experimental treatment for anthrax infection. The company said the U.S. Food and Drug Administration (FDA) issued a complete response letter asking for additional information relating to its ...

  • FDA questions delay approval of Human Genome Sciences anthrax drug raxibacumab 17 Nov 2009 05:18 GMT
    ... said Monday that approval of its experimental anthrax drug hit a delay as regulators asked the ... the firm for more information about the treatment. The Food and Drug Administration wrote in ...

  • Md. firm's anthrax drug delayed 17 Nov 2009 12:36 GMT
    ... said Monday that approval of its experimental anthrax drug hit a delay as regulators asked the ... the firm for more information about the treatment. The Food and Drug Administration wrote in ...

  • HGS's anthrax drug delayed by FDA 17 Nov 2009 02:32 GMT
    ... ...

  • HGSI's ABthrax Faces FDA Delay - Analyst Blog 17 Nov 2009 18:53 GMT
    ... ) announced that the U.S. Food and Drug Administration (FDA) delayed the approval of ABthrax ... of ABthrax (raxibacumab), the company’s candidate for anthrax treatment, asking for additional information pertaining to the ...

  • Human Genome Sciences Receives Complete Response Letter from FDA for Raxibacumab Biologics License Application 17 Nov 2009 01:12 GMT
    ... Response Letter from the U.S. Food and Drug Administration (FDA) relating to the Company's Biologics ... approval of raxibacumab for use in the treatment of inhalational anthrax. The FDA issues Complete Response Letters to ...

  • Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN'˘ 25 Nov 2009 12:30 GMT
    ... Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for ... (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission ... drugs to treat lupus, hepatitis C, inhalation anthrax and cancer. The Company's primary focus is ...

  • Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN(TM) 25 Nov 2009 12:30 GMT
    ... Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN(TM) (albinterferon alfa-2b) for ... (FDA) for ZALBIN(TM) (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission ... drugs to treat lupus, hepatitis C, inhalation anthrax and cancer. The Company's primary focus is ...

  • Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN 25 Nov 2009 12:32 GMT
    ... Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN (albinterferon alfa-2b) for ... (FDA) for ZALBIN (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission ... drugs to treat lupus, hepatitis C, inhalation anthrax and cancer. The Company's primary focus is ...

  • www.StockMarketingInc.com: Check Us Out!!! Sign Up Now For Our Free Newsletter!! HGSI,AFFX,CNQR,CONN,DMAN,DNDN 25 Nov 2009 14:57 GMT
    ... Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN(TM) (albinterferon alfa-2b) for ... (FDA) for ZALBIN(TM) (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission ... drugs to treat lupus, hepatitis C, inhalation anthrax and cancer. The Company's primary focus is ...


1 - 15 / 118      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ANTHRAX DRUGS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

send press release
EIN PRESSWIRE

Press Release Distribution Service
see all health press releases »see all press releases »

list your company
EINDIRECTORY

add listing
EINEVENTS

get free trial
EINNEWS PUBLICATIONS

FORMATS: RSS

EIN News Columnists

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Health Industry News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Science & Technology News

MORE ARTICLES >>>

Take This Poll

Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009)



 
FORMATS: RSS | EMAIL

Health Insurance News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Health Regulation News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Public Health News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Drugs News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Cancer News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Disease News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Nutrition News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Aging News

MORE ARTICLES >>>

Healthcare Industry Today

Health & Healthcare News Sections
Drugs & Pharmaceuticals News Sections
Health News by Region
Health News by Country
Health News by U.S. State

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

ALL NEWS PUBLICATIONS

You are currently reading Healthcare Industry Today, an EIN News publication.

EIN News provides breaking news coverage on the following topics:

Regional / Politics
Barack Obama
Central Europe
China
EU Politics
Hillary Clinton
International Development
Military
Russia
US Politics
World News
Automotive
Automotive
Electric Cars
Hybrid Cars
Trucks		 Energy
Biofuels
Electric Power
Energy
Ethanol
Geothermal Power
Nuclear Power
Oil & Gas
Power Plants
Renewable Energy
Solar Energy
Wind Energy
Health / Pharmaceuticals
Brain Cancer
Breast Cancer
H1N1
Health
Lung Cancer
Mesothelioma
Pharmaceuticals
Prostate Cancer		 Business / Finance
Banking
Conferences
Employment
FOREX Trading
Finance
Gold
International Trade
Investing
Marketing
Real Estate
Science / Technology
Biotechnology
Environment
Global Warming
IT
Nanotechnology
Semiconductors
Software
Technology		 Culture / Society / Lifestyle
Books
Consumer
Human Rights
Media
Movies
Music
Religion
Travel
Company Daily Reports
Airbus
BP Energy
Boeing
Coca-Cola
ConocoPhillips
Exxon Mobil
Gazprom
Pepsi-Cola
Shell Energy
Starbucks		 Industry
Agriculture
Airlines
Chemicals
Cosmetics
Mining
Mobile Phone
Patents & Trademarks
Shipping & Logistics
Textiles
Tobacco
Waste Management
Food / Beverages
Beverages
Fast Food
Food Industry
Food Safety
Organic Food
Seafood

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.

EIN News © 1995 - 2009 IPD Group, Inc. All Rights Reserved. | User Agreement | Privacy Policy | Contact